Intra-Cellular Therapies SEC Filings & 10K Form (NASDAQ:ITCI)

$8.54
-0.20 (-2.29 %)
(As of 09/20/2019 04:00 PM ET)
Add
Compare
Today's Range
$8.28
Now: $8.54▼
$8.80
50-Day Range
$8.11
MA: $9.04▼
$10.38
52-Week Range
$7.41
Now: $8.54▼
$23.62
Volume1.56 million shs
Average Volume680,190 shs
Market Capitalization$471.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19

SEC Filings

Intra-Cellular Therapies (NASDAQ:ITCI) SEC Filings

DateFilerForm TypeView
09/12/2019
11:15 PM		Intra-Cellular Therapies (Filer)
Form EFFECT
09/12/2019
4:06 PM		Intra-Cellular Therapies (Filer)
Form 424B3
09/12/2019
4:02 PM		Intra-Cellular Therapies (Filer)
Form 424B3
09/11/2019
3:30 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
6:39 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
5:24 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
7:24 PM		Intra-Cellular Therapies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/07/2019
3:16 PM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
7:08 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
6:37 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
5:07 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
6:10 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
8:17 AM		Intra-Cellular Therapies (Filer)
Form CT ORDER
07/02/2019
4:17 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:12 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:48 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:47 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:45 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:43 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:33 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:31 PM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
4:50 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
4:48 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
06/14/2019
4:23 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:31 PM		Intra-Cellular Therapies (Filer)
Form DEFA14A
05/31/2019
3:35 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
5:03 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:35 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:16 PM		Intra-Cellular Therapies (Filer)
Form DEF 14A
04/02/2019
6:03 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
5:59 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
5:56 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
5:52 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
6:41 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:32 PM		Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
6:43 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
5:50 AM		Intra-Cellular Therapies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2019
3:45 PM		BlackRock Inc. (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
01/10/2019
3:28 PM		Intra-Cellular Therapies (Issuer)
Satlin Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
3:18 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:28 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:24 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:21 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:19 PM		Intra-Cellular Therapies (Issuer)
Vanover Kimberly E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:16 PM		Davis Robert E (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
8:02 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:58 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:46 PM		Intra-Cellular Therapies (Issuer)
Vanover Kimberly E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:42 PM		Davis Robert E (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:23 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:19 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:15 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:11 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:05 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:39 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2018
6:02 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
4:55 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
6:15 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
3:44 PM		Davis Robert E (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
4:34 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
3:32 PM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
6:17 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
3:33 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2018
3:28 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2018
3:13 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2018
7:11 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
7:08 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
7:06 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
7:01 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:17 PM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
6:17 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
3:27 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
3:20 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
3:17 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:21 PM		Intra-Cellular Therapies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/21/2018
3:32 PM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
3:52 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:49 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:47 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:45 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:40 PM		Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
6:15 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
3:06 PM		Intra-Cellular Therapies (Filer)
Form DEFA14A
04/27/2018
3:01 PM		Intra-Cellular Therapies (Filer)
Form DEF 14A
04/03/2018
3:33 PM		Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:31 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:19 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
6:44 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2018
3:11 PM		Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2018
6:07 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2018
3:38 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
2:35 PM		BB BIOTECH AG (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
02/09/2018
8:25 AM		Intra-Cellular Therapies (Subject)
Form SC 13G/A
02/01/2018
3:01 PM		Intra-Cellular Therapies (Subject)
Sosland Morton I. (Filed by)
Form SC 13G/A
01/24/2018
6:11 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2018
8:05 PM		Intra-Cellular Therapies (Issuer)
Vanover Kimberly E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2018
8:01 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
6:03 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2018
7:19 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2018
7:14 PM		Intra-Cellular Therapies (Issuer)
Vanover Kimberly E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Featured Article: Exchange-Traded Funds (ETFs)
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel